SRPT
$17.10-3.88%
Sarepta Therapeutics Inc. Common Stock (DE)Stock · HealthcareRussell 2000 0.06%Nasdaq Composite 0.005%US Stock Market 0.002%Russell 3000 0.002%
SRPT financial statements
The full income statement, balance sheet, and cash-flow statement for Sarepta Therapeutics Inc. Common Stock (DE) (SRPT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 95.4M2024-09 95.5M2024-12 97.0M2025-03 98.3M2025-06 97.7M2025-09 104.8M2025-12 105.0M2026-03 105.6M2026-06 105.6M+10.8% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 2.20B+22.9% | 1.79B+43.8% | 1.24B+33.3% | 933M+32.9% | 702M+30.0% | |
| Cost of revenue | 25.5M | — | — | — | — | |
| Research & development | 1.52B+89.2% | 805M-8.3% | 877M+0.0% | 877M+13.7% | 771M+6.8% | |
| Selling, general & administrative | 492M-11.9% | 558M+15.8% | 482M+6.7% | 451M+59.7% | 283M-11.1% | |
| Restructuring | 42.0M | 0.00 | 0.00 | — | — | |
| Amortization of intangibles | 2.62M+9.0% | 2.40M+54.3% | 1.56M+118.3% | 714K+1.1% | 706K+6.6% | |
| Operating income | -700M-420.9% | 218M+181.4% | -268M+50.1% | -536M-16.6% | -460M+18.5% | |
| Interest expense | -38.1M-107.4% | -18.4M+16.4% | -22.0M+58.7% | -53.2M-183.8% | 63.5M+6.0% | |
| Interest & investment income | 30.8M+0.4% | 30.6M-15.5% | 36.3M+119.9% | 16.5M+4557.6% | 354K-88.1% | |
| Other non-operating income | -19.3M-145.2% | 42.7M+29.2% | 33.1M+216.7% | -28.3M+53.8% | -61.2M-11944.9% | |
| Equity-method income | 0.00 | 0.00+100.0% | -30.3M-1077.5% | -2.58M | — | |
| Pre-tax income | -702M-369.3% | 261M+150.1% | -520M+24.6% | -690M-64.7% | -419M+24.2% | |
| Income tax | 11.2M-56.2% | 25.5M+60.8% | 15.9M+17.4% | 13.5M+8150.6% | -168K-115.8% | |
| -713M-403.3% | 235M+143.9% | -536M+23.8% | -703M-68.0% | -419M+24.4% | ||
| Net income to common | -713M-403.3% | 235M+143.9% | -536M | — | — | |
| -$7.13-404.7% | $2.34+140.3% | -$5.80+27.8% | -$8.03-55.9% | -$5.15+27.6% | ||
| EPS (basic) | -$7.13-388.7% | $2.47+142.6% | -$5.80+27.8% | -$8.03-55.9% | -$5.15+27.6% | |
| Weighted-avg shares (basic) | 100M+5.3% | 95.1M+2.9% | 92.4M+5.5% | 87.6M+7.7% | 81.3M+4.2% | |
| Weighted-avg shares (diluted) | 100M-7.2% | 108M+16.8% | 92.4M+5.5% | 87.6M+7.7% | 81.3M+4.2% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 2.54B-17.4% | 3.07B+19.2% | 2.58B+0.8% | 2.56B-1.8% | 2.60B+4.8% | ||
| Cash & equivalents | 801M-27.4% | 1.10B+157.5% | 428M-55.7% | 967M-54.3% | 2.12B+40.8% | |
| Short-term investments | 138M-45.0% | 252M-79.8% | 1.25B+22.0% | 1.02B | 0.00-100.0% | |
| Cash & short-term investments | — | — | 1.69B-15.8% | 2.01B-5.5% | 2.13B+9.1% | |
| Accounts receivable | 398M-33.8% | 602M+50.4% | 400M+86.5% | 215M+40.3% | 153M+51.0% | |
| Inventory | 915M+22.0% | 750M+132.3% | 323M+58.3% | 204M+9.5% | 186M-19.7% | |
| Other current assets | 172M+90.0% | 90.5M+16.4% | 77.7M-48.2% | 150M+0.6% | 149M-30.1% | |
| 3.35B-15.5% | 3.96B+21.4% | 3.26B+4.4% | 3.13B-0.6% | 3.15B+5.5% | ||
| Property, plant & equipment | 345M+1.4% | 340M+49.8% | 227M+26.2% | 180M-5.8% | 191M+0.4% | |
| Operating lease right-of-use | 125M-15.4% | 148M+14.1% | 130M+100.1% | 65.0M+42.7% | 45.5M-50.4% | |
| Intangible assets | 28.9M+7.7% | 26.9M-9.2% | 29.6M+290.9% | 7.58M-46.8% | 14.2M+4.5% | |
| Long-term investments | 1.05M-99.2% | 133M | 0.00 | — | — | |
| Other non-current assets | 156M+94.6% | 79.9M-41.6% | 137M-16.1% | 163M-44.4% | 293M+43.8% | |
| 1.10B+49.7% | 732M+11.9% | 654M+5.5% | 620M+36.9% | 453M+8.8% | ||
| Accounts payable | 281M+31.0% | 214M+30.0% | 165M+72.0% | 95.9M+24.9% | 76.7M-30.9% | |
| Accrued liabilities | 360M-3.7% | 374M+18.6% | 315M-24.8% | 419M+54.2% | 272M+40.4% | |
| Deferred revenue | 443M+240.4% | 130M+158.4% | 50.4M-43.5% | 89.2M+0.0% | 89.2M+0.0% | |
| Short-term & current debt | — | 0.00-100.0% | 105M | 0.00 | — | |
| Current lease liability | 11.2M-15.6% | 13.3M-25.6% | 17.8M+15.2% | 15.5M+2.9% | 15.0M-28.1% | |
| Other current liabilities | 11.4M-15.4% | 13.5M-24.5% | 17.8M+15.2% | 15.5M+2.9% | 15.1M-32.0% | |
| 2.21B-9.3% | 2.44B+1.3% | 2.41B-12.3% | 2.74B+23.6% | 2.22B-0.1% | ||
| Long-term debt | 829M-27.1% | 1.14B-8.1% | 1.24B-19.8% | 1.54B+174.0% | 564M | |
| Deferred revenue (non-current) | 83.9M-74.2% | 325M-25.6% | 437M-9.9% | 485M-15.5% | 574M-13.5% | |
| Non-current lease liability | 199M+3.6% | 192M+36.5% | 141M+144.8% | 57.6M+38.7% | 41.5M-48.3% | |
| Operating lease liability (total) | 211M+2.3% | 206M+29.6% | 159M+117.3% | 73.1M+29.2% | 56.6M-44.2% | |
| Other non-current liabilities | 1.53M-12.6% | 1.75M-41.7% | 3.00M+7042.9% | 42.0K-99.6% | 11.0M-44.4% | |
| 1.14B-25.3% | 1.53B+77.8% | 859M+123.2% | 385M-58.5% | 928M+21.8% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 11.0K+10.0% | 10.0K+11.1% | 9.00K+0.0% | 9.00K+0.0% | 9.00K+12.5% | |
| Additional paid-in capital | 6.04B+5.3% | 5.74B+8.2% | 5.30B+23.5% | 4.30B+3.9% | 4.13B+14.5% | |
| Retained earnings | -4.88B-15.8% | -4.21B+5.3% | -4.45B-13.7% | -3.91B-21.9% | -3.21B-12.6% | |
| Treasury stock | 25.3M | 0.00 | — | — | — | |
| Accumulated other comprehensive income | 272K+224.8% | -218K-123.7% | 918K+155.2% | -1.66M-8220.0% | -20.0K-766.7% | |
| Total liabilities & equity | 3.35B-15.5% | 3.96B+21.4% | 3.26B+4.4% | 3.13B-0.6% | 3.15B+5.5% | |
| Common shares issued | 106M+9.0% | 96.9M+3.4% | 93.7M+6.6% | 88.0M+0.9% | 87.1M+9.8% | |
| Common shares outstanding | 105M+8.3% | 96.9M+3.4% | 93.7M+6.6% | 88.0M+0.9% | 87.1M+9.8% | |
| Shares outstanding (cover) | 105M+8.2% | 97.0M+3.4% | 93.9M+6.7% | 88.0M+1.0% | 87.1M+9.7% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -205M+0.1% | -206M+58.9% | -501M-54.0% | -325M+26.6% | -443M-512.4% | ||
| Depreciation & amortization | 44.5M+18.0% | 37.7M-15.0% | 44.4M+6.1% | 41.9M+10.1% | 38.0M+41.3% | |
| Intangible amortization | 2.62M+9.0% | 2.40M+54.3% | 1.56M+118.3% | 714K+1.1% | 706K+6.6% | |
| Share-based compensation | 123M-33.0% | 184M+1.0% | 183M-21.7% | 233M+104.5% | 114M+5.4% | |
| Deferred income taxes | -363K-45.8% | -249K-50.9% | -165K+73.0% | -612K-98.1% | -309K-26.1% | |
| Change in receivables | -204M-201.0% | 202M+8.6% | 186M+201.3% | 61.6M+19.3% | 51.6M+393.7% | |
| Change in inventory | 301M-23.8% | 395M+167.5% | 148M+190.9% | 50.8M-39.4% | 83.8M+38.3% | |
| 69.6M-90.8% | 756M+555.7% | -166M+84.2% | -1.05B-311.3% | 495M+507.0% | ||
| Capital expenditure | 102M-25.5% | 137M+80.0% | 76.1M+146.9% | 30.8M-19.9% | 38.5M-53.2% | |
| Free cash flow | -307M+10.3% | -343M+40.6% | -577M-62.0% | -356M+26.1% | -482M-2006.5% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -168M-234.9% | 125M-0.2% | 125M-46.2% | 233M-58.6% | 562M-17.7% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 20.0M | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock repurchased | 25.0M | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -304M-145.1% | 675M+224.5% | -542M+52.5% | -1.14B-285.7% | 614M-8.1% | |
| Interest paid | 14.9M-5.9% | 15.9M-0.4% | 15.9M-64.2% | 44.4M-20.6% | 55.9M+62.6% | |
| Income taxes paid | 37.6M+66.6% | 22.6M+49.8% | 15.1M+789.7% | 1.70M+190.7% | 583K-76.8% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 2.26B-80.8% | 11.8B+30.8% | 9.02B-20.7% | 11.4B+44.9% | 7.85B-42.0% | |
| P/E | — | 50.2× | — | — | — | |
| P/S | 1.0×-84.4% | 6.6×-19.2% | 8.2×-37.1% | 13.0×+16.1% | 11.2×-55.4% | |
| P/B | 2.0×-74.4% | 7.7×-34.6% | 11.8×-55.3% | 26.4×+212.2% | 8.5×-52.4% | |
| Earnings yield | — | 2.0% | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: SRPT’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all SRPT filings on SEC EDGAR → Not investment advice.